Dr Lal Pathlabs Latest News

  1. Dr Lal Pathlabs has informed that a meeting of the Board of Directors is scheduled to be held on Thursday, February 08, 2018 to consider and approve the un-audited Financial Results of the Company for the Quarter ended December...

    Date:29-12-2017
  2. The company's subsidiary has decided to acquire 100% stake in SPDC with the objective of strengthening its presence in market
    Date:13-12-2017
  3. The company's subsidiary has decided to acquire 100% stake in SPDC with the objective of strengthening its presence in market
    Date:13-12-2017
  4. Dr. Lal PathLabs has informed that the Board of Directors of the Company at its meeting held on November 09, 2017, has declared an interim dividend of Rs 1.50 per equity share (at 15% on a face value of Rs 10 per share) for the...

    Date:09-11-2017
  5. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional I...

    Date:28-09-2017
  6. This is pursuant to due compliance of the order from Government of National Capital Territory of Delhi, Health and Family Welfare Department
    Date:28-09-2017
  7. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meet...

    Date:18-09-2017
  8. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meet...

    Date:15-09-2017
  9. Prior to the company’s investment, DLPLB shall be acquiring the running diagnostics business of a sole-proprietorship firm in Dhaka, Bangladesh
    Date:07-08-2017
  10. Dr Lal Pathlabs has informed that a meeting of the Board of Directors is scheduled to be held on Monday, August 07, 2017 to consider and approve the unaudited Financial Results of the Company for the Quarter ended June 30, 2017...

    Date:30-06-2017
Return to Top
Connect with us Facebook
Connect with us Facebook
Connect with us Linkedin
Connect with us Pintrest
Connect with us Google Plus
Connect with us You Tube
Connect with us Mobile App
 
 
Request a Call Back
Mobile
Invalid Mobile Number
x
Thanks. We will call you shortly.